BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4029510)

  • 1. Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes.
    Jones RL
    Diabetes; 1985 Sep; 34(9):836-43. PubMed ID: 4029510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fibrinopeptide A levels during insulin-induced plasma glucose falls in diabetics.
    Ishii M; Kameyama M; Inokuchi T; Isogai S
    Diabetes Res Clin Pract; 1987 Nov; 4(1):45-50. PubMed ID: 3319468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia may determine fibrinopeptide A plasma level increase in humans.
    Ceriello A; Giugliano D; Quatraro A; Dello Russo P; Marchi E; Torella R
    Metabolism; 1989 Dec; 38(12):1162-3. PubMed ID: 2593829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of coagulation in diabetes mellitus in relation to the presence of vascular complications.
    Ford I; Singh TP; Kitchen S; Makris M; Ward JD; Preston FE
    Diabet Med; 1991 May; 8(4):322-9. PubMed ID: 1830255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-thromboglobulin in diabetes: relationships with blood glucose and fibrinopeptide A.
    Burrows AW
    Horm Metab Res Suppl; 1981; 11():22-5. PubMed ID: 6172350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
    Yoda Y; Abe T
    Thromb Haemost; 1981 Dec; 46(4):706-9. PubMed ID: 7330820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-thromboglobulin and fibrinopeptide A in diabetes mellitus as markers of vascular damage.
    Librenti MC; D'Angelo A; Micossi P; Garimberti B; Mannucci PM; Pozza G
    Acta Diabetol Lat; 1985; 22(1):39-45. PubMed ID: 2408434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus.
    Rosove MH; Frank HJ; Harwig SS
    Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
    Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
    J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.
    Eisenberg PR; Lucore C; Kaufman L; Sobel BE; Jaffe AS; Rich S
    Circulation; 1990 Sep; 82(3):841-7. PubMed ID: 2394005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes.
    Ganda OP; Arkin CF
    Diabetes Care; 1992 Oct; 15(10):1245-50. PubMed ID: 1425083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinopeptide A and the phosphate content of fibrinogen in venous thromboembolism and disseminated intravascular coagulation.
    Leeksma OC; Meijer-Huizinga F; Stoepman-van Dalen EA; van Ginkel CJ; van Aken WG; van Mourik JA
    Blood; 1986 May; 67(5):1460-7. PubMed ID: 3697510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T
    Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of plasma fibrinopeptide A and high molecular weight fibrinogen in patients with liver cirrhosis.
    Coccheri S; Mannucci PM; Palareti G; Gervasoni W; Poggi M; ViganĂ² S
    Br J Haematol; 1982 Nov; 52(3):503-9. PubMed ID: 7126483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of thrombin generation and platelet secretion in diabetes mellitus.
    Rosove MH; Berliner JA; Harwig SS; Frank HJ
    Diabetes Res; 1985 Jul; 2(4):171-3. PubMed ID: 2935351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of fibrinopeptide A (FPA) and fibrinopeptide B beta 15-42 (FPB beta) in urine and plasma after urokinase administration in patients with chronic glomerulonephritis.
    Miura M; Tomino Y; Inoue W; Yagame M; Tamura S; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1986 Oct; 11(4):273-7. PubMed ID: 3617111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias.
    Mombelli G; Roux A; Haeberli A; Straub PW
    Blood; 1982 Aug; 60(2):381-8. PubMed ID: 7093524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between fibrinopeptide a (FPA) level and fibrinogen kinetics in patients with malignant disease.
    Yoda Y; Nakamura H; Abe T
    Bibl Haematol; 1983; (49):163-72. PubMed ID: 6667244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinopeptide A during normal pregnancy.
    Romero R; Rickles FR; Matthews E; Scott D; Dinan C; Duffy T
    Am J Perinatol; 1988 Jan; 5(1):70-3. PubMed ID: 3257391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.